VASCULAR SURGERY
Peripheral Artery Disease / Peripheral Vascular Disease
Atherosclerosis of the peripheral arteries – peripheral artery disease ( PAD ) or peripheral vascular disease ( PVD ) – is a growing health issue in America . Vascular surgeons on the medical staff of Baylor Scott & White Heart and Vascular Hospital – Dallas successfully diagnose and treat thousands of patients annually for PAD and PVD issues . Using advanced digital imaging technology , minimally invasive surgical techniques and pharmacological approaches , the experience of vascular surgeons on the medical staff extends to conditions such as :
• Peripheral artery disease ( PAD )
• Intestinal ischemic syndrome
• Renovascular occlusive disease
• Popliteal entrapment syndrome
• Vasospastic disorders
• Inflammatory vascular disease
• Hypercoagulable states
• Deep vein thrombosis ( DVT )
• Pulmonary embolism
• Axillo-subclavian vein thrombosis
• Superficial thrombophlebitis
LOWER EXTREMITY PAD
While the incidence of PAD is on the rise , lower extremity disease can be especially serious and challenging . Narrowing of the arteries can restrict blood circulation to the legs and feet , resulting in pain , weakness and other issues including ulcers and hard-to-heal wounds . Vascular surgeons on the medical staff at the hospital see patients from throughout North Texas and the nation . Initially using a conservative approach to treatment , the vascular surgeons may recommend lifestyle changes coupled with medications . If these approaches are not effective , intervention may be required . Vascular surgeons on the medical staff may perform an angioplasty , place a stent or perform a bypass . In other cases , the vascular surgeon may opt for using a thrombolytic agent to dissolve a blood clot that may be blocking an artery .
Vascular surgeons on the medical staff often treat patients with circulatory disorders related to May-Thurner syndrome and other venous obstructive disorders . Patients come from throughout the region as a result of the surgeons ’ experience with complex patients and involvement in worldwide clinical trials .
43